Bioanalytical Systems, Inc. (BASI) Issues Earnings Results
Bioanalytical Systems, Inc. (NASDAQ:BASI) announced its quarterly earnings results on Monday. The company reported $0.03 EPS for the quarter, Bloomberg Earnings reports. Bioanalytical Systems had a negative return on equity of 29.32% and a negative net margin of 8.95%. The company had revenue of $5.84 million during the quarter.
Bioanalytical Systems (NASDAQ:BASI) opened at 1.71 on Tuesday. Bioanalytical Systems has a 12 month low of $0.60 and a 12 month high of $2.42. The stock’s market cap is $14.00 million. The firm’s 50-day moving average price is $1.78 and its 200 day moving average price is $1.49.
An institutional investor recently raised its position in Bioanalytical Systems stock. Vanguard Group Inc. raised its stake in shares of Bioanalytical Systems, Inc. (NASDAQ:BASI) by 12.3% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 112,296 shares of the company’s stock after buying an additional 12,300 shares during the period. Vanguard Group Inc. owned approximately 1.37% of Bioanalytical Systems worth $190,000 at the end of the most recent quarter. 3.91% of the stock is currently owned by institutional investors and hedge funds.
Bioanalytical Systems Company Profile
Bioanalytical systems, Inc is an international contract research company providing drug discovery and development services and analytical instruments. The Company operates in two segments: contract research services and research products. The contract research services segment provides research and development support on a contract basis to pharmaceutical companies.
Receive News & Ratings for Bioanalytical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioanalytical Systems Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.